Adma Biologics, Inc. ADMA
2 targets with a reported result
Releases of the last 3 yearsThe numbers ADMA said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2027 |
Given $455.00M release Jan 12, 2026
|
– | No standard number | |
The company's wordsFY 2027 Adjusted EBITDA expected to be approximately $455 million release Jan 12, 2026 | ||||
| Net income (company-defined) Fiscal 2027 |
Given $315.00M release Jan 12, 2026
|
– | No standard number | |
The company's wordsFY 2027 Adjusted Net Income expected to be approximately $315 million release Jan 12, 2026 | ||||
| Revenue Fiscal 2027 |
Given $775.00M release Jan 12, 2026
|
– | Not reported yet | |
The company's wordsFY 2027 total revenue expected to be approximately $775 million release Jan 12, 2026 | ||||
| EBITDA (company-defined) Fiscal 2026 |
Given $360.00M release Jan 12, 2026
Lowered $265.00M to $300.00M release May 6, 2026
Kept $265.00M to $300.00M release Aug 5, 2026
|
– | No standard number | |
The company's wordsFY 2026 expected Adjusted EBITDA increased to approximately $360 million, up from $355 million previously release Jan 12, 2026 FY 2026 Adjusted EBITDA expected to be $265 million to $300 million release May 6, 2026 FY2026 Adjusted EBITDA expected to be $265 million to $300 million release Aug 5, 2026 | ||||
| Net income (company-defined) Fiscal 2026 |
Given $255.00M release Jan 12, 2026
Lowered $170.00M to $200.00M release May 6, 2026
Kept $170.00M to $200.00M release Aug 5, 2026
|
– | No standard number | |
The company's wordsFY 2026 expected Adjusted Net Income reiterated at approximately $255 million release Jan 12, 2026 FY 2026 Adjusted Net Income expected to be $170 million to $200 million release May 6, 2026 FY2026 Adjusted Net Income expected to be $170 million to $200 million release Aug 5, 2026 | ||||
| Revenue Fiscal 2026 |
Given $635.00M release Jan 12, 2026
Lowered $530.00M to $560.00M release May 6, 2026
Kept $530.00M to $560.00M release Aug 5, 2026
|
– | Not reported yet | |
The company's wordsFY 2026 expected total revenue increased to approximately $635 million, up from $630 million previously release Jan 12, 2026 FY 2026 total revenue expected to be $530 million to $560 million release May 6, 2026 FY2026 total revenue expected to be $530 million to $560 million release Aug 5, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $220.00M to $300.00M release Jan 13, 2025
Raised $235.00M to $340.00M release Aug 6, 2025
|
– | No standard number | |
The company's wordsFY 2025 and 2026 Adjusted EBITDA expected to exceed $220 million and $300 million, respectively release Jan 13, 2025 FY 2025 and 2026 Adjusted EBITDA reaffirmed to be more than $235 million and $340 million or more, respectively release Aug 6, 2025 | ||||
| Net income Fiscal 2025 (ended Dec 31, 2025) |
Given $170.00M to $230.00M release Jan 13, 2025
|
$146.93M 10-K filed 2026-02-25 |
Below the range | |
The company's wordsFY 2025 and 2026 net income expected to exceed $170 million and $230 million, respectively release Jan 13, 2025 | ||||
| Net income (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given $175.00M to $245.00M release Aug 6, 2025
|
– | No standard number | |
The company's wordsFY 2025 and 2026 Adjusted Net Income reaffirmed to be more than $175 million and $245 million or more, respectively release Aug 6, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $485.00M to $600.00M release Jan 13, 2025
Raised $500.00M to $625.00M release Aug 6, 2025
|
$510.17M 10-K filed 2026-02-25 |
Within the range | |
The company's wordsFY 2025 and 2026 total revenue expected to exceed $485 million and $600 million, respectively release Jan 13, 2025 FY 2025 and 2026 total revenue reaffirmed to be more than $500 million and $625 million or more, respectively release Aug 6, 2025 | ||||
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Revenue, Fiscal 2024 (ended Dec 31, 2024): said $320.00M, reported $426.45M. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2024-01-08), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ADMA/export.csv") into a cell.